175 related articles for article (PubMed ID: 22352893)
21. New I-type lectins of the CD 33-related siglec subgroup identified through genomics.
Crocker PR; Zhang J
Biochem Soc Symp; 2002; (69):83-94. PubMed ID: 12655776
[TBL] [Abstract][Full Text] [Related]
22. Siglec-5 and Siglec-14 are polymorphic paired receptors that modulate neutrophil and amnion signaling responses to group B Streptococcus.
Ali SR; Fong JJ; Carlin AF; Busch TD; Linden R; Angata T; Areschoug T; Parast M; Varki N; Murray J; Nizet V; Varki A
J Exp Med; 2014 Jun; 211(6):1231-42. PubMed ID: 24799499
[TBL] [Abstract][Full Text] [Related]
23. Cloning and molecular characterization of two splice variants of a new putative member of the Siglec-3-like subgroup of Siglecs.
Foussias G; Taylor SM; Yousef GM; Tropak MB; Ordon MH; Diamandis EP
Biochem Biophys Res Commun; 2001 Jun; 284(4):887-99. PubMed ID: 11409877
[TBL] [Abstract][Full Text] [Related]
24. Constitutive repressor activity of CD33 on human monocytes requires sialic acid recognition and phosphoinositide 3-kinase-mediated intracellular signaling.
Lajaunias F; Dayer JM; Chizzolini C
Eur J Immunol; 2005 Jan; 35(1):243-51. PubMed ID: 15597323
[TBL] [Abstract][Full Text] [Related]
25. Role of Siglecs on the leucocytes during the process of the joint's inflammation in rheumatoid arthritis.
Yang X; Wang Y
Med Hypotheses; 2011 Dec; 77(6):1051-3. PubMed ID: 21955923
[TBL] [Abstract][Full Text] [Related]
26. Common determinants of severe Covid-19 infection are explicable by SARS-CoV-2 secreted glycoprotein interaction with the CD33-related Siglecs, Siglec-3 and Siglec-5/14.
Murch SH
Med Hypotheses; 2020 Nov; 144():110168. PubMed ID: 33254494
[TBL] [Abstract][Full Text] [Related]
27. Siglecs take a TOLL on inflammation: deciphering the Hsp70 riddle.
Calderwood SK; Murshid A
EMBO J; 2015 Nov; 34(22):2733-4. PubMed ID: 26474574
[TBL] [Abstract][Full Text] [Related]
28. Viewing Siglecs through the lens of tumor immunology.
Fraschilla I; Pillai S
Immunol Rev; 2017 Mar; 276(1):178-191. PubMed ID: 28258691
[TBL] [Abstract][Full Text] [Related]
29. Siglecs at the Host-Pathogen Interface.
Chang YC; Nizet V
Adv Exp Med Biol; 2020; 1204():197-214. PubMed ID: 32152948
[TBL] [Abstract][Full Text] [Related]
30. Loss of Siglec expression on T lymphocytes during human evolution.
Nguyen DH; Hurtado-Ziola N; Gagneux P; Varki A
Proc Natl Acad Sci U S A; 2006 May; 103(20):7765-70. PubMed ID: 16682635
[TBL] [Abstract][Full Text] [Related]
31. Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo.
Duong BH; Tian H; Ota T; Completo G; Han S; Vela JL; Ota M; Kubitz M; Bovin N; Paulson JC; Nemazee D
J Exp Med; 2010 Jan; 207(1):173-87. PubMed ID: 20038598
[TBL] [Abstract][Full Text] [Related]
32. CD33 as a leukocyte-associated marker expressed on human spermatozoa.
Sereshki N; Rafiee M; Alipour R; Rahimyan K; Wilkinson D
BMC Res Notes; 2023 Apr; 16(1):57. PubMed ID: 37081561
[TBL] [Abstract][Full Text] [Related]
33. Cell death modulation by intravenous immunoglobulin.
von Gunten S; Simon HU
J Clin Immunol; 2010 May; 30 Suppl 1():S24-30. PubMed ID: 20405180
[TBL] [Abstract][Full Text] [Related]
34. Human-specific expression of Siglec-6 in the placenta.
Brinkman-Van der Linden EC; Hurtado-Ziola N; Hayakawa T; Wiggleton L; Benirschke K; Varki A; Varki N
Glycobiology; 2007 Sep; 17(9):922-31. PubMed ID: 17580316
[TBL] [Abstract][Full Text] [Related]
35. Siglec-8 and Siglec-F, the new therapeutic targets in asthma.
Farid SSh; Mirshafiey A; Razavi A
Immunopharmacol Immunotoxicol; 2012 Oct; 34(5):721-6. PubMed ID: 22324980
[TBL] [Abstract][Full Text] [Related]
36. Group B Streptococcus suppression of phagocyte functions by protein-mediated engagement of human Siglec-5.
Carlin AF; Chang YC; Areschoug T; Lindahl G; Hurtado-Ziola N; King CC; Varki A; Nizet V
J Exp Med; 2009 Aug; 206(8):1691-9. PubMed ID: 19596804
[TBL] [Abstract][Full Text] [Related]
37. A study of CD33 (SIGLEC-3) antigen expression and function on activated human T and NK cells: two isoforms of CD33 are generated by alternative splicing.
Hernández-Caselles T; Martínez-Esparza M; Pérez-Oliva AB; Quintanilla-Cecconi AM; García-Alonso A; Alvarez-López DM; García-Peñarrubia P
J Leukoc Biol; 2006 Jan; 79(1):46-58. PubMed ID: 16380601
[TBL] [Abstract][Full Text] [Related]
38. Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer.
Rabinovich GA; Croci DO
Immunity; 2012 Mar; 36(3):322-35. PubMed ID: 22444630
[TBL] [Abstract][Full Text] [Related]
39. A novel function of Siglec-9 A391C polymorphism on T cell receptor signaling.
Cheong KA; Chang YS; Roh JY; Kim BJ; Kim MN; Park YM; Park HJ; Kim ND; Lee CH; Lee AY
Int Arch Allergy Immunol; 2011; 154(2):111-8. PubMed ID: 20733319
[TBL] [Abstract][Full Text] [Related]
40. Analysis of the CD33-related siglec family reveals that Siglec-9 is an endocytic receptor expressed on subsets of acute myeloid leukemia cells and absent from normal hematopoietic progenitors.
Biedermann B; Gil D; Bowen DT; Crocker PR
Leuk Res; 2007 Feb; 31(2):211-20. PubMed ID: 16828866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
